Home | List of Topics | Cancer | Cancer - General
SVC obstruction is a narrowing or blockage of the superior vena cava -- the second largest vein in the human body. The superior vena cava moves blood from the upper half of the body to the heart.
Superior vena cava (SVC) obstruction is a relatively rare condition.
Most often it is caused by cancer in the mediastinum (the area of the chest under the breastbone and between the lungs). The types of cancer that can lead to this condition include lymphoma, cancer of the lung that spreads, breast cancer, testicular cancer, thyroid cancer, and thymic tumors.
Superior vena cava obstruction can also be caused by noncancerous conditions that cause chronic fibrosis (scarring). These conditions include lung infections (such as tuberculosis), histoplasmosis infection, and thrombophlebitis.
Other causes of superior vena cava obstruction include aortic aneurysm, constrictive pericarditis, and goiter.
An examination may show enlarged veins of the face, neck, and upper chest. Blood pressure is often high in the arms and low in the legs.
A bronchoscopy may be performed if lung cancer is suspected.
Obstruction of the SVC may show on:
This disease may also alter the results of the following tests:
The goal of treatment is relief of the obstruction.
Diuretics may be used to relieve swelling.
The cause must be identified and treated. This may include radiation, chemotherapy, surgical removal of tumors, or other treatment. Surgery to bypass the obstruction is rarely performed. Placement of a stent to open up the SVC is available at some medical centers.
The outcome varies depending on the cause and the extent of obstruction.
The throat could swell and block the airways.
Call your health care provider if a lung tumor is present and symptoms indicate SVC obstruction may be present. Complications are serious and can sometimes be fatal.
Prompt treatment of other medical disorders may reduce the risk of developing SVC obstruction.
Review Date:5/3/2006
Reviewed By:William Matsui, MD, Assistant Professor of Oncology, Division of Hematologic Malignancies, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.
Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.